Hi there!
I’m Dahham, a postdoctoral researcher at Stanford University School of Medicine focusing on inflammatory bowel disease (IBD). My current work investigates molecular and clinical determinants of biologic therapy outcomes using longitudinal real-world data. Through this research, I aim to reduce trial-and-error treatment approaches and strengthen evidence-based clinical decision-making, ultimately improving outcomes and quality of life for individuals living with IBD.
